Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-22

FDA Approved: CRESEMBA — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

The FDA approved Astellas' supplemental application for Cresemba (isavuconazonium sulfate), finalizing changes to its labeling. The action updates the antifunga…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cresemba (isavuconazole)

Snippet

SUPPL AP for CRESEMBA (ISAVUCONAZONIUM SULFATE)